Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours

J Ford, E Cummins, P Sharma, A Elders, F Stewart, R Johnston, P Royle, R Jones, C Mulatero, R Todd, G Mowatt

Research output: Contribution to journalArticle

25 Citations (Scopus)
564 Downloads (Pure)

Abstract

Denosumab offers an alternative, or additional, treatment for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumours.
Original languageEnglish
Pages (from-to)1-386
Number of pages386
JournalHealth Technology Assessment
Volume17
Issue number29
DOIs
Publication statusPublished - Jul 2013

Fingerprint Dive into the research topics of 'Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours'. Together they form a unique fingerprint.

  • Cite this

    Ford, J., Cummins, E., Sharma, P., Elders, A., Stewart, F., Johnston, R., Royle, P., Jones, R., Mulatero, C., Todd, R., & Mowatt, G. (2013). Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours. Health Technology Assessment, 17(29), 1-386. https://doi.org/10.3310/hta17290